pharma · Asthma · Pharmacokinetics · AMPH
Amphastar France Pharmaceuticals
Amphastar France Pharmaceuticals clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga
- Founded
- 1996
- Employees
- 46
- Programs
- 18
- Drugs
- 15
- Patents
- 15
Amphastar France Pharmaceuticals projects
9 ClinicalTrials.gov programs sponsored by Amphastar France Pharmaceuticals.
Amphastar France Pharmaceuticals has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
A006
Amphastar France Pharmaceuticals
Asthma
1 trial -
A006 DPI
Amphastar France Pharmaceuticals
Asthma
2 trials -
API-E004-CL-A
Amphastar France Pharmaceuticals
Asthma
1 trial -
API-E004-CL-B4
Amphastar France Pharmaceuticals
Asthma
1 trial -
Albuterol DPI 25 mcg/inh
Amphastar France Pharmaceuticals
Asthma
1 trial -
Arm T1: Primatene Mist HFA
Amphastar France Pharmaceuticals
Asthma
1 trial -
Epinephrine Inhalation Aerosol, HFA
Amphastar France Pharmaceuticals
Asthma
1 trial -
Hyaluronidase
Amphastar France Pharmaceuticals
Allergic Skin Reaction
1 trial -
albuterol inhalation powder
Amphastar France Pharmaceuticals
Asthma
1 trial
Frequently asked questions
How many clinical projects does Amphastar France Pharmaceuticals have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.